Skip to content
Thursday, November 12, 2026
Life Desk

Users Discontinuing Slimming Injections Put On Weight Far More Rapidly Than People Using Diet and Exercise

Image of pharmaceutical injection and scale
Obesity treatment involves long-term strategies.

Fresh analysis suggests that patients who come off popular GLP-1 drugs like Wegovy and Mounjaro can put back on lost weight far faster than those who end traditional lifestyle regimens.

Findings released in a prominent medical journal shows that while obese people frequently drop about a fifth of their body weight while using the jabs, the mass is regained at an average rate of nearly a kilo each month after stopping.

"Users using such drugs need to be informed of the danger of quick rebound weight gain when the medication is stopped," warns expert Dr. Susan Jebb.

Such speed of regain means a reversion to starting weight in about one and a half years.

Analyzing Treatments

The research, which examined 37 of studies involving thousands of participants, contrasted the effects of GLP-1 agonists with older methods.

Researchers note that people who shed pounds through lifestyle changes alone usually experience a slower weight regain—approximately 100 grams monthly—after stopping.

Explaining the Fast Regain

Nutrition scientists suggest the mechanism of the injections is key to understanding the accelerated weight return.

The injections imitate a body's own chemical called GLP-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 levels far above than the body's typical production might result in the system to produce less of its own natural GLP-1, and may also lessen responsiveness to its actions," explained Dr. Adam Collins, a dietetics expert.

"Discontinuation of this medication results in appetite is no longer kept in check, making binge eating far more likely."

A Lifelong Disease?

The NHS recommend the jabs for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

Professionals say that, given the significant potential of relapse, the treatment is often long-term.

This view is echoed by drug manufacturers, who note that the results "underscore the persistent character of obesity," akin to managing conditions like hypertension.

Patient Experiences

People who have stopped the jabs report a sudden resurgence of hunger.

"It was like something activating and you become extremely hungry," said a patient.

This challenge is exacerbated if users have not established lasting dietary or behavioural changes during treatment.

Widespread Adoption

Figures show that millions of adults in the UK have used these injections in the last 12 months, with desire remaining high.

  • Adoption is greater among females than males.
  • The middle-aged age group shows the highest level of interest.
  • A large proportion access the drugs through private healthcare rather than the NHS.

In conclusion, experts stress that while these medications are powerful tools for shedding pounds, they are not a standalone solution and long-term success likely depends on integrated lifestyle management.

CH
Written by

Christine Holland

Emily Thornton is a lifestyle writer passionate about helping others find balance and joy in their everyday routines.

Life Desk

Type to search articles.